Loading…
Old Pascua Community Land Acquisition Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
98pct
515d open
vs 9,698 other HR bills in the 117th — cohort avg 63d
Old Pascua Community Land Acquisition Act This act directs the Department of the Interior to take tribally owned lands in Pima County, Arizona, into trust for the benefit of the Pascua Yaqui Tribe of Arizona. Lands taken into trust shall be part of the Pascua Yaqui Reservation. The act allows gaming on the land taken into trust.
Yes
375
No
45
Present
1
Not Voting
10
Party Breakdown
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2024 · first_quarter · Medicare/Medicaid
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Became Public Law No: 117-275.
Became Public Law No: 117-275.
Signed by President.
Signed by President.
Presented to President.
Presented to President.
Message on Senate action sent to the House.
Passed Senate without amendment by Unanimous Consent. (consideration: CR S7291)
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.
Placed on Senate Legislative Calendar under General Orders. Calendar No. 432.
Committee on Indian Affairs. Reported by Senator Schatz without amendment. With written report No. 117-127.
Bills with similar content found using semantic analysis.
Sources: Congress.gov · House Clerk roll-call votes
| house |
| On Motion to Suspend the Rules and Pass |
Passed |
| November 2, 2021 |
Client expense: $4,803,802 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · fourth_quarter · Medicare/Medicaid
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act S.3430 - Better Mental Health Care, Lower-Cost Drugs, and Extenders Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Client expense: $5,294,628 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · third_quarter · Medicare/Medicaid
Issues related to prescription drug coverage and pharmacy benefits Regulatory and proposed legislative changes to Medicare Part D prescription drug benefits S.652 - Safe Step Act S.1038 - Drug Price Transparency in Medicaid Act S.1130 - Health Care PRICE Transparency Act S.1131 - Drug Price Transparency Act S.1217 - Ending the Prescription Drug Kickback Act S.1375 - HELP Copays Act S.1491 - Pharmacy and Medically Underserved Areas Enhancement Act S.1967 - Patients Before Middlemen (PBM) Act S.2052 - Protect Patient Access to Pharmacies Act S.2129 - Ensuring Access to Lower-Cost Medicines for Seniors Act S.2254 - Medicare PBM Accountability Act S.2405 - Strengthening Pharmacy Access for Seniors Act S.2406 - PBM Oversight Act S.2408 - IMPROVE Part D Regulations Act S.2436 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act S.2456 - Protecting Seniors from High Drug Costs Act S.2474 - Share the Savings with Seniors Act S.2477 - Equitable Community Access to Pharmacist Services Act S.2493 - PBM Reporting Transparency Act S.2939 - Pharmacy Access Oversight and Reporting Act S.2973 - Modernizing and Ensuring PBM Accountability Act H.R.830 - HELP Copays Act H.R.1352 - Increasing Access to Biosimilars Act H.R.1613 - Drug Price Transparency in Medicaid Act H.R.1770 - Equitable Community Access to Pharmacists Act H.R.2630 - Safe Step Act H.R.2666 - Medicaid VBPs for Patients (MVP) Act H.R.2670 - PBM Accountability Act H.R.2691 - Transparent PRICE Act H.R.2880 - Protecting Patients Against PBM Abuses Act H.R.3262 - to amend title XI of the Social Security Act to increase transparency of certain health-related ownership information H.R.3281 - Transparent PRICE Act H.R.3282 - Promoting Transparency and Health Competition in Medicare Act H.R.3285 - Fairness for Patient Medications H.R.3561- Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act H.R.4011 - Timely Access to Clinical Treatment Act H.R.4881 - To amend title XVIII of the Social Security Act to limit cost sharing for drugs under the Medicare program H.R.4883 - Medicare Common Ownership Transparency Act H.R.5372 - Expanding Seniors Access to Lower Cost Medicines Act H.R.5376 - Share the Savings with Seniors Act H.R.5378 - Lower Costs More Transparency Act H.R.5384 - Advancing Enrollment and Reducing Drug Costs Act H.R.5385 - Medicare PBM Accountability Act H.R.5386 - Cutting Copays Act H.R.5393-Transparency and Fairness for Pharmacies Act H.R.5400 - Neighborhood Options for Patients Buying Medicines (NO PBM) Act H.R.5461 - Ensuring Access to Lower-Cost Medicines for Seniors Act Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation
Client expense: $3,973,758 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Indian/Native American Affairs
HR.4881 The Old Pascua Land Acquisition Act. This bill would put 30 acres of land into trust for the Pascua Yaqui Tribe.
Client expense: Not reported · Firm income: $60,000
2022 · fourth_quarter · Indian/Native American Affairs
HR.4881 The Old Pascua Land Acquisition Act. This bill would put 30 acres of land into trust for the Pascua Yaqui Tribe.
Client expense: Not reported · Firm income: $60,000
2022 · fourth_quarter · Indian/Native American Affairs
HR.4881 The Old Pascua Land Acquisition Act. This bill would put 30 acres of land into trust for the Pascua Yaqui Tribe.
Client expense: Not reported · Firm income: $30,000
2022 · fourth_quarter · Food Industry (safety, labeling, etc.)
Working to have FDA enforce beef standards of identity on vegetable-based alternative protein products. Working to have FSIS regulate cultured or lab grown alternative protein products and to restrict their use of the term beef. HR4881/S3016 Real MEAT Act. DIRECT Act-H.R. 547 H.R. 4140 Butcher Block Act Oppose S. 2716/H.R. 7291 Mandatory Country-of-origin labeling
Client expense: $40,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · third_quarter · Food Industry (safety, labeling, etc.)
Working to have FDA enforce beef standards of identity on vegetable-based alternative protein products. Working to have FSIS regulate cultured or lab grown alternative protein products and to restrict their use of the term beef. HR4881/S3016 Real MEAT Act. DIRECT Act-H.R. 547 H.R. 4140 Butcher Block Act Oppose S. 2716/H.R. 7291 Mandatory Country-of-origin labeling
Client expense: $40,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · second_quarter · Food Industry (safety, labeling, etc.)
Working to have FDA enforce beef standards of identity on vegetable-based alternative protein products. Working to have FSIS regulate cultured or lab grown alternative protein products and to restrict their use of the term beef. HR4881/S3016 Real MEAT Act. DIRECT Act-HR547
Client expense: $40,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2022 · first_quarter · Food Industry (safety, labeling, etc.)
Working to have FDA enforce beef standards of identity on vegetable-based alternative protein products. Working to have FSIS regulate cultured or lab grown alternative protein products and to restrict their use of the term beef. HR4881/S3016 Real MEAT Act. RAMP UP Act DIRECT Act
Client expense: $40,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2021 · fourth_quarter · Food Industry (safety, labeling, etc.)
Working to have FDA enforce beef standards of identity on vegetable-based alternative protein products. Working to have FSIS regulate cultured or lab grown alternative protein products and to restrict their use of the term beef. HR4881/S3016 Real MEAT Act. RAMP UP Act DIRECT Act
Client expense: $40,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commodity Futures Trading Commission (CFTC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
2021 · fourth_quarter · Budget/Appropriations
FY22 Agriculture Appropriations Bill provisions impacting the cattle industry. FY22 Transportation-HUD Appropriations Bill regarding provisions impacting livestock haulers. House and Senate Interior-EPA Appropriations bills to defund regulatory work directed at collecting greenhouse gas reports from manure management systems and permitting livestock methane emissions under CAA Title V. Real Marketing Edible Artificials Truthfully (MEAT) Act and HR 4881. Funding for Foot and Mouth Disease Vaccine Bank. FY22 funding to update Army Corps of Engineer study on interbasin water transfer. American Rescue Plan Act of 2021. HR3684 Infrastructure Investment & Jobs Act.
Client expense: $40,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commodity Futures Trading Commission (CFTC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
2021 · third_quarter · Budget/Appropriations
FY22 Agriculture Appropriations Bill provisions impacting the cattle industry. FY22 Transportation-HUD Appropriations Bill regarding provisions impacting livestock haulers. House and Senate Interior-EPA Appropriations bills to defund regulatory work directed at collecting greenhouse gas reports from manure management systems and permitting livestock methane emissions under CAA Title V. Real Marketing Edible Artificials Truthfully (MEAT) Act and HR 4881. Funding for Foot and Mouth Disease Vaccine Bank. FY22 funding to update Army Corps of Engineer study on interbasin water transfer. American Rescue Plan Act of 2021.
Client expense: $40,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commodity Futures Trading Commission (CFTC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
2021 · third_quarter · Food Industry (safety, labeling, etc.)
Working to have FDA enforce beef standards of identity on vegetable-based alternative protein products. Working to have FSIS regulate cultured or lab grown alternative protein products and to restrict their use of the term beef. HR4881/S3016 Real MEAT Act. RAMP UP Act DIRECT Act
Client expense: $40,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commodity Futures Trading Commission (CFTC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
2021 · second_quarter · Budget/Appropriations
FY22 Agriculture Appropriations Bill provisions impacting the cattle industry. FY22 Transportation-HUD Appropriations Bill regarding provisions impacting livestock haulers. House and Senate Interior-EPA Appropriations bills to defund regulatory work directed at collecting greenhouse gas reports from manure management systems and permitting livestock methane emissions under CAA Title V. Real Marketing Edible Artificials Truthfully (MEAT) Act and HR 4881. Funding for Foot and Mouth Disease Vaccine Bank. FY22 funding to update Army Corps of Engineer study on interbasin water transfer. American Rescue Plan Act of 2021. Coronavirus Food Assistance Program (CFAP).
Client expense: $40,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commodity Futures Trading Commission (CFTC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
2021 · second_quarter · Food Industry (safety, labeling, etc.)
Working to have FDA enforce beef standards of identity on vegetable-based alternative protein products. Working to have FSIS regulate cultured or lab grown alternative protein products and to restrict their use of the term beef. HR4881/S3016 Real MEAT Act. RAMP UP Act DIRECT Act
Client expense: $40,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commodity Futures Trading Commission (CFTC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
2021 · first_quarter · Food Industry (safety, labeling, etc.)
Working to have FDA enforce beef standards of identity on vegetable-based alternative protein products. Working to have FSIS regulate cultured or lab grown alternative protein products and to restrict their use of the term beef. HR4881/S3016 Real MEAT Act. RAMP UP Act DIRECT Act
Client expense: $40,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commodity Futures Trading Commission (CFTC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
2021 · first_quarter · Budget/Appropriations
FY21 Agriculture Appropriations Bill provisions impacting the cattle industry. FY21 Transportation-HUD Appropriations Bill regarding provisions impacting livestock haulers. House and Senate Interior-EPA Appropriations bills to defund regulatory work directed at collecting greenhouse gas reports from manure management systems and permitting livestock methane emissions under CAA Title V. Real Marketing Edible Artificials Truthfully (MEAT) Act and HR 4881. Funding for Foot and Mouth Disease Vaccine Bank. FY21 funding to update Army Corps of Engineer study on interbasin water transfer. American Rescue Plan Act of 2021. Coronavirus Food Assistance Program (CFAP).
Client expense: $40,000 · Firm income: Not reported
Government targets: Agriculture, Dept of (USDA), Commodity Futures Trading Commission (CFTC), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), Transportation, Dept of (DOT), U.S. Trade Representative (USTR), White House Office
Committee on Indian Affairs. Ordered to be reported without amendment favorably.
Committee on Indian Affairs. Hearings held. Hearings printed: S.Hrg. 117-115.
Received in the Senate and Read twice and referred to the Committee on Indian Affairs.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 375 - 45, 1 Present (Roll no. 346). (text: 11/1/2021 CR H6048-6049)
HousePassed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 375 - 45, 1 Present (Roll no. 346).(text: 11/1/2021 CR H6048-6049)
HouseConsidered as unfinished business. (consideration: CR H6097-6098)
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
DEBATE - The House proceeded with forty minutes of debate on H.R. 4881.
Considered under suspension of the rules. (consideration: CR H6048-6050)
Ms. Leger Fernandez moved to suspend the rules and pass the bill.
Placed on the Union Calendar, Calendar No. 121.
Reported by the Committee on Natural Resources. H. Rept. 117-166.
Congress.gov source codes: 5000, H12200
Ordered to be Reported by Unanimous Consent.
Committee Consideration and Mark-up Session Held.
Subcommittee for Indigenous Peoples of the United States Discharged.
Subcommittee Hearings Held.
Referred to the Subcommittee for Indigenous Peoples of the United States.
Referred to the House Committee on Natural Resources.
Introduced in House
Congress.gov source codes: 1000, Intro-H
| Referred to |
| November 3, 2021 |
| Natural Resources Committee | House | Reported by | November 1, 2021 |
| Natural Resources Committee | House | Markup by | October 13, 2021 |
| Natural Resources Committee | House | Referred to | July 30, 2021 |
| November 2, 2021 |
| Reported in House | November 1, 2021 |
| Introduced in House | July 30, 2021 |
| Enrolled Bill | -- |
| Democratic |
| AZ |
| Jesús G. "Chuy" García | Democratic | IL |
| Kaiali’i Kahele | Democratic | HI |
| Paul A. Gosar | Republican | AZ |
| Ruben Gallego | Democratic | AZ |
| Teresa Leger Fernandez | Democratic | NM |
| Tom O’Halleran | Democratic | AZ |